Renal effects of angiotensin II receptor blockade in normotensive subjects (Q41066761)

26 September 2017

1 reference

title

Renal effects of angiotensin II receptor blockade in normotensive subjects (English)

1 reference

26 September 2017

Burnier M

1

1 reference

26 September 2017

Roch-Ramel F

series ordinal

2

1 reference

26 September 2017

Brunner HR

series ordinal

3

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 June 1996

1 reference

26 September 2017

1 reference

26 September 2017

49

1 reference

26 September 2017

6

1 reference

26 September 2017

1787-1790

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.1996.268

26 September 2017

0 references

cites work

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.268

7 January 2021

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.268

7 January 2021

Angiotensin converting enzyme inhibitors and progressive renal insufficiency. Current experience and future directions

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.268

7 January 2021

Bradykinin causes selective efferent arteriolar dilation during angiotensin I converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.268

7 January 2021

Sodium intake and renal responses to captopril in normal man and in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.268

7 January 2021

The effects of enalapril on blood pressure and the kidney in normotensive subjects under altered sodium balance

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.268

7 January 2021

Effects of DuP 753 on Renal Function of Normotensive and Spontaneously Hypertensive Rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.268

7 January 2021

The role of endogenous angiotensin II in the regulation of renal haemodynamics and proximal fluid reabsorption in the rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.268

7 January 2021

Effects of the Nonpeptide Angiotensin II Receptor Antagonist DuP 753 on Blood Pressure and Renal Functions in Spontaneously Hypertensive PH Dogs

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.268

7 January 2021

Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.268

7 January 2021

Studies of the renal effects of angiotensin II receptor blockade: the confounding factor of acute water loading on the action of vasoactive systems

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.268

7 January 2021

Short-term and sustained renal effects of angiotensin II receptor blockade in healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.268

7 January 2021

Dose-ranging study of the angiotensin type I receptor antagonist losartan (DuP753/MK954), in salt-deplete normal man

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.268

7 January 2021

Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.268

7 January 2021

Effects of enalapril on renal sodium handling in healthy subjects on low, intermediate, and high sodium intake

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.268

7 January 2021

Proximal nephron and renal effects of DuP 753, a nonpeptide angiotensin II receptor antagonist

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.268

7 January 2021

Pilot study of the uricosuric effect of DuP-753, a new angiotensin II receptor antagonist, in healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.268

7 January 2021

Pharmacodynamic activity of intravenous E-3174, an angiotensin II antagonist, in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.268

7 January 2021

Clinical pharmacology of the angiotensin II receptor antagonist losartan potassium in healthy subjects.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.268

7 January 2021

Effects of losartan on a background of hydrochlorothiazide in patients with hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.268

7 January 2021

Antihypertensive efficacy and tolerability of once daily losartan potassium compared with captopril in patients with mild to moderate essential hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.268

7 January 2021

Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.268

7 January 2021

Identifiers

DOI

10.1038/KI.1996.268

1 reference

Dimensions Publication ID

26 September 2017

1039203602

0 references

Fatcat ID

release_yv4ryqlg6ra7hoirgc4af6yyhq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yv4ryqlg6ra7hoirgc4af6yyhq

24 November 2022

mapped directly with Wikidata item

1 reference